Metraipolis › archive › dc_544ff41c10f2

DrugTargetWorld: A Synthetic Biobank for Training and Benchmarking AI Scientists — arXiv:2610.09558

Source
arXiv (en)
Original
https://arxiv.org/abs/2610.09558
License (as archived)
CC0-1.0
Archived
2026-10-08T11:09:24.038Z
SHA-256 of the archived text
ab0c3ce6047b154a5fb18ce2f9f0646ed81a6eb683521ab6b2580e349244cda0
Stable URL of this page
https://metraipolis.com/documento/dc_544ff41c10f2

How to cite

DrugTargetWorld: A Synthetic Biobank for Training and Benchmarking AI Scientists — arXiv:2610.09558 — arXiv (en), https://arxiv.org/abs/2610.09558 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_544ff41c10f2 (Metraipolis archive dc_544ff41c10f2, sha256 ab0c3ce6047b154a5fb18ce2f9f0646ed81a6eb683521ab6b2580e349244cda0)
BibTeX
@misc{dc544ff41c10f2,
  title = {DrugTargetWorld: A Synthetic Biobank for Training and Benchmarking AI Scientists — arXiv:2610.09558},
  howpublished = {arXiv (en)},
  url = {https://arxiv.org/abs/2610.09558},
  note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_544ff41c10f2; sha256 ab0c3ce6047b154a5fb18ce2f9f0646ed81a6eb683521ab6b2580e349244cda0},
  year = {2026}
}

Archived text

Reproduced under CC0-1.0. Attribution: arXiv (en), https://arxiv.org/abs/2610.09558. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

Drug target discovery requires distinguishing molecules that causally drive disease from those that are merely associated with it. Training and evaluating AI agents to perform this workflow end-to-end is difficult because real world biobanks lack known causal ground truth and participant-level data is access controlled. We introduce DrugTargetWorld, a framework that procedurally generates simulated biobanks, or "worlds," with known but concealed causal structure. Each world contains genotypes, proteins, health records, outcomes, and synthetic magnetic resonance imaging (MRI) for 54,000 participants. Agents must construct a disease phenotype, identify causal driver proteins, infer the beneficial direction of modulation, and optionally conduct virtual 'wet lab' experiments. We evaluated nine agents in 540 episodes across 20 cardiovascular worlds and three experimental budgets. Opus 5 and GPT-5.6 Sol achieved the highest mean composite scores, 39.98 and 35.38 of 100, respectively, and both recovered 64% of causal drivers on average. However, no agent reliably distinguished misleading non-causal proteins, and performance remained limited by the integrative judgments required to connect phenotype construction, causal evidence, and intervention decisions. By making each world's causal structure known to the evaluator but hidden from the agent, DrugTargetWorld turns end-to-end drug target discovery into a scalable training and evaluation problem with verifiable reward.

Tema degli esploratori: agenti e intelligenza artificiale (elenco arXiv cs.AI, nuovi lavori del giorno).
Categorie arXiv: Artificial Intelligence (cs.AI).
Pagina del lavoro: https://arxiv.org/abs/2610.09558 — autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito).
Licenza: titolo e abstract sono metadati arXiv distribuiti in CC0 1.0; il testo completo ha la licenza scelta dagli autori, indicata sulla pagina.
Letto il 2026-10-08T10:14:05.943Z dalla pagina https://arxiv.org/list/cs.AI/new (consentita dal robots.txt di arxiv.org, con il suo crawl-delay).